[Abstract] Tumorigenicity refers to the ability of cultured cells to develop viable tumors in immune-deficient animals. The goal of this protocol is to illustrate tumorigenicity assay by subcutaneous tumor-cell-transplantation in nude mice. Target cells are transplanted to 6-week-old nude mice subcutaneously and the tumor growth is monitored over a period of observation or treatment.
mice is a widely used experiment to monitor tumor growth in vivo (Giovanella et al., 1974) . The most commonly used animal system for tumorigenicity assay is athymic nude mouse (Petricciani et al., 1973) where malignant cells can be transplanted either subcutaneously or subrenal-capsularly (van Meir, 1997 ). For cells with relatively low ability of tumorigenicity, take rate can be improved by irradiation (30-60 Gy) or implantation in Matrigel (Pretlow et al., 1991) . Tumorigenicity assay provides a means of generating human cell derived tumor tissues for measurement of tumor cell malignancy and evaluation for anti-tumor drug efficacy. 3. Pellet cells at 60 x g for 5 min, remove supernatant and resuspend cells homogeneously in
PBS.
Note: Cells should be resuspended into monoplast suspension for cell counting.
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Data analysis
1. Tumor size and weight of different groups are presented as the mean ± SD., which are adapted for tumor growth curve.
2. Differences between means were assessed using Student's t-test. P < 0.05 was considered to be statistically significant.
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Notes
It is recommended to perform a small pilot study to determine the tumor take rate before the formal experiments. Additional cells and mice needed if the take rate is less than 100%.
Recipes
Complete 1640 medium 10% FBS
1% penicillin-streptomycin 2 mM glutamine
